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ABSTRACT
In eukaryotes, translation termination is performed
by eRF1, which recognizes stop codons via its
N-terminal domain. Many previous studies based
on point mutagenesis, cross-linking experiments or
eRF1 chimeras have investigated the mechanism by
which the stop signal is decoded by eRF1. Conserved
motifs, such as GTS and YxCxxxF, were found to be
important for termination efficiency, but the recogni-
tion mechanism remains unclear. We characterized a
region of the eRF1 N-terminal domain, the P1 pocket,
that we had previously shown to be involved in ter-
mination efficiency. We performed alanine scanning
mutagenesis of this region, and we quantified in vivo
readthrough efficiency for each alanine mutant. We
identified two residues, arginine 65 and lysine 109,
as critical for recognition of the three stop codons.
We also demonstrated a role for the serine 33 and
serine 70 residues in UGA decoding in vivo. NMR
analysis of the alanine mutants revealed that the cor-
rect conformation of this region was controlled by the
YxCxxxF motif. By combining our genetic data with
a structural analysis of eRF1 mutants, we were able
to formulate a new model in which the stop codon
interacts with eRF1 through the P1 pocket.
INTRODUCTION
Translation termination is mediated by a complex of class 1
and 2 release factors (RFs) (1). When a stop codon (UAA,
UAG or UGA) enters the A site of the ribosome, a class 1
RFdecodes it and induces peptide release by stimulating the
peptidyl-transferase centre before ribosome recycling (2).
Unlike prokaryotes, which use two release factors––RF1
(decoding UAA and UAG) and RF2 (decoding UAA and
UGA)––eukaryotes have only one class 1 release factor,
eRF1. This protein has three distinct domains: N, M and
C (3,4). The N-terminal domain (N) is responsible for stop
codon recognition (5); the central domain (M) is involved
in peptide hydrolysis, via its methylated GGQ motif (6–8);
and theC-terminal domain (C) interacts with the class 2RF,
eRF3, which stimulates termination activity by triggering a
change in the conformation of eRF1 (9,10).
The X-ray structures of RF1 or RF2 within the ribosome
have provided important information about the recogni-
tion of stop codons in prokaryotes (11). In eukaryotes, only
medium-resolution CryoEM maps are available and, de-
spite considerable progress in recent years, the exact mech-
anism by which stop codons are decoded remains unclear
(12,13). Regions in the N-terminal domain of eRF1 in-
volved in stop codon decoding have been identified on the
basis of biochemical and genetic data. Cross-linking experi-
ments (14,15), mutagenesis (16,17) and biochemical studies
(18) implicated the universally conserved TASNIKS motif
(positions 58–64, human numbering) in stop codon decod-
ing. Two other motifs YxCxxxF (positions 125–131) and
GTS (positions 31–33) have also been shown to be involved
in distinguishing the purine bases in the second and third
positions of the stop codon (19,20). Much of the available
information about the role of the N domain in stop codon
recognition came from studies of chimeric eRF1s contain-
ing regions of the N domain from organisms using variant
genetic codes (18,21–24). In particular, analyses of the N
domains of unipotent or bipotent ciliate eRF1s led to the
identification of residues critical for stop codon recognition
specificity. Determination of the structure of the human
eRF1 N domain by nuclear magnetic resonance (NMR) re-
vealed that the GTS loop could adopt different conforma-
tions, which were modulated by mutations surrounding this
loop, with an impact on stop codon recognition specificity
(25). Cross-linking experiments also showed this motif to
be proximal to the guanine residues in the second or third
position but more distal to the adenine residues in the sec-
ond or third position of the stop codon. Mutagenesis of
the conserved residues in the N-terminal domain of human
eRF1 identified amino acids crucial for discrimination be-
tween adenine and guanine residues in the second and third
positions of the stop codon (26). This in vitro study sug-
gested that residues S33 and S70 would be involved in gua-
nine recognition at the second position, and that the decod-
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ing of adenines at this position would involve T32, S36 and
F131 (from the YxCxxxF motif). For the decoding of the
third base of the stop codon, they suggested that residues
E55, Y125 (from the YxCxxxF motif) and N129 would rec-
ognize guanines, whereas the valine in position 71 would
be involved in the recognition of adenine residues. The cur-
rent model for stop codon recognition by eRF1, based on
the latest data from cross-linking and mutagenesis studies,
involves two steps, including a change in the conformation
of the termination factor governed by the purine residues
present in positions 2 and 3 within the stop codon. Support
for this model was provided by the recent observation of
changes in the conformation of eRF1 following the dissoci-
ation of eRF3 and the binding of ABCE1 (13). Indeed, the
authors observed that the eRF1 N domain appeared to be
‘fragmented’ in their cryoEM maps, indicating conforma-
tional flexibility. However, the data obtained in the presence
of eRF3 were highly consistent with previously obtained
cryoEM data and confirmed the proximity of the NIKS,
GTS and YxCxxxF motifs to the stop codon (12). Despite
the large number of studies carried out and the models pro-
posed, the mechanism of stop codon recognition remains
poorly understood. This may be due to the diversity of sys-
tems used to assay eRF1 activity and the lack of in vivo data
concerning the eRF1 residues involved in stop codon de-
coding.
We previously identified two pockets (P1 and P2) in-
volved in termination efficiency, by screening hyperactive
mutants of eRF1 (27). In this study, we aimed to charac-
terize the role of the P1 cavity, which is located close to the
NIKSmotif, in more detail. We performed an alanine scan-
ning experiment on all the residues of P1 and carried out
an NMR analysis of proteins with a mutated N domain,
to identify the residues of P1 involved in stop codon recog-
nition (Figure 1). We identified two positions (R65 and
K109, human numbering) for which mutation to yielded
alanine residues greatly decreased termination efficiency,
for all stop codons. Two other mutations, the S33A and
S70A mutations, decreased termination efficiency specifi-
cally for UGA stop codons. We then carried out an NMR
analysis of the structure of the N-terminal domain of hu-
man eRF1 mutants, for the characterization of these mu-
tantswith particular termination phenotypes. Replacing the
serine 70 residue with an alanine residue had almost no im-
pact on the local conformation of the N domain of human
eRF1, whereas the S33A, R65A and K109A mutations in-
duced local changes in the conformation of the N domain,
with a particularly strong impact on the highly conserved
YxCxxxF motif. Our genetic data and the NMR analysis
revealed that some P1 pocket residues interacted directly
with the stop codon, whereas others helped to position the
mRNA correctly. These findings led us to propose a two-
stepmodel, in which the stop codon on themRNA interacts
directly with eRF1 via the P1 cavity.
MATERIALS AND METHODS
Strains and media
The Rosetta (DE3) pLysS Escherichia coli strain (F− ompT
hsdSB(RB− mB−) gal dcm (DE3 [lacI lacUV5-T7 gene 1
ind1 sam7 nin5]) pLysSRARE (CamR)) is a derivative of
strain BL21. It was used for production of the heRF1 N-
terminal domain. This strain was grown in M9-based min-
imal medium supplemented with 15N-ammonium sulphate
as the nitrogen source for protein labelling.
The FS1SUP45 Saccharomyces cerevisiae strain
(MAT ΔSUP45::ADE2 ade2-592 lys2Δ201 leu2-3,112
his3Δ200 ura3-52) is a derivative of FS1 (MAT ade2-592
lys2Δ201 leu2-3,112 his3Δ200 ura3-52). It was used for the
production of mutant forms of Sup45p (the yeast eRF1)
(27). As SUP45 is essential in yeast, this strain also carries
a wild-type copy of the gene on a plasmid, pFL44L (p2,
SUP45, URA3). We used 5FOA at a concentration of 1
mg/ml to select for the loss of URA3 plasmids. This strain
was used to quantify the efficiency of the readthrough
conferred by Sup45p mutants.
Plasmids
Sequences encoding heRF1 proteins with mutated N do-
mains and an N-terminal 6xhis tag were inserted into
pET29 (KanR). They were expressed under the control of
T7 promoters, following induction with IPTG (isopropyl -
D-1-thiogalactopyranoside).
The mutant SUP45 (encoding the yeast eRF1) and ETF1
(encoding the human eRF1) sequences were inserted into
the PvuII restriction site of pHS8, a derivative of pFL61
(p2, HIS3). The various mutant SUP45 and ETF1 se-
quences were expressed under control of the SUP45 pro-
moter.
Western blot
Protein samples were subjected to electrophoresis in sodium
dodecyl sulphate–polyacrylamide gels and the resulting
bands were then electroblotted onto PVDFmembrane at 16
V for 45 min. Monoclonal antibodies raised against eRF1
(a gift from Vale´rie Heurgue´-Hamard) were hybridized to
the membranes and primary antibody binding was detected
by incubation with alkaline phosphatase-conjugated sec-
ondary antibodies and NBT/BCIP staining.
Quantification of readthrough efficiency
The pAC derivative vectors were constructed by inserting
the fragment of interest into the single MscI site of pAC99
(28). Luciferase and -galactosidase activities were assayed
in the same crude extract, as previously described (29). Data
are reported as box plots, withmedian values for at least five
independent measurements. The significance of differences
was evaluated in nonparametric Mann–Whitney tests.
Purification of the heRF1 N domain
For heRF1 N domain purification, the Rosetta (DE3)
pLysS strain was transformed with the various pET29
constructs. IPTG (1 mM) was added to a 2-l culture at
OD600 of 0.4 to induce expression of the protein at 23◦C
overnight. The culture was centrifuged to obtain a cell pel-
let, which was resuspended in Tris buffer containing 20-
mM Tris pH 7.5, 200-mM NaCl, 10-mM imidazole, 6-mM
-mercaptoethanol and 1× Complete ethylenediaminete-
traacetic acid-free protease inhibitor cocktail. Cells were
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Figure 1. P1 pocket residues mutated to alanine. Representation of the structure of eRF1, with the three domains and the conserved NIKS and GGQ
motifs indicated. The magnified view shows the surface of the P1 pocket. The residues mutated to alanines are shown in red.
disrupted with a French press and by sonication, and the
resulting whole-cell extract was applied to a 1-ml HisTrap
HP column (GE Healthcare). The N domain was purified
with an AKTA purifier10 FPLC system, in which heRF1-
Nter was bound to the resin in the presence of resuspen-
sion buffer without protease inhibitors. Proteins were eluted
from the affinity column with a Tris-imidazole buffer con-
taining 20-mMTris pH7.5, 200-mMNaCl, 500-mM imida-
zole and 6-mM -mercaptoethanol. Non-specific contami-
nants were removed from the samples in a second purifica-
tion step. Centrifugal filters (Sartorius Vivaspin) were used
to replace the buffer of the sample eluted from the HisTrap
column with a buffer containing 100-mMNaCl but no imi-
dazole, for purification on an anion exchange column (QFF
from GE Healthcare). The sample was applied to a 1-ml Q
FF column in a Tris-NaCl buffer (20-mM Tris pH 7.5, 100-
mMNaCl and 6-mM -mercaptoethanol) and the proteins
were eluted with a 1-M NaCl gradient.
NMR studies of the heRF1 N domain
NMR experiments were carried with a 4-channel, 5-
amplifier 14.1 T (600 MHz 1H) Bruker AVANCE 3 spec-
trometer equipped with a 5-mm QCI-F cryoprobe and
Bruker TopSpin software. All experiments were conducted
at 298 K, with Shigemi NMR tubes (BMS-005B) and refer-
encing based on the resonance of water and the relative gy-
romagnetic ratio for 15N [13]. 1H-15N HSQC spectra were
collected with 2048 and 256 points in F2 and F1, respec-
tively, and a spectral width of 16 ppm for 1H and 18.5
ppm for 15N. The data were processed with NMRPipe [16]
and analysed with the CCPN Analysis package [17, 18].
Chemical shift assignments were determined by compar-
ison with previously published assignments from BMRB
18092 and confirmed with 15N-edited TOCSY andNOESY
NMR spectra for the wild-type protein.
RESULTS
Yeast eRF1 mutants and associated phenotypes
We characterized the P1 pocket, by assessing the contribu-
tion of each of its residues to termination efficiency.We gen-
erated an alanine scanning mutant for each position in this
region, by performing directed mutagenesis on the pHS8-
SUP45 plasmid. All the positions mutated are represented
in Figure 1, using human numbering. We will use human
numbering to designate the mutations throughout this ar-
ticle, for the sake of clarity. The FS1SUP45 S. cerevisiae
strain was transformed with the mutant constructs and the
plasmid bearing the wild-type SUP45 gene copy was shuf-
fled out by 5-FOA counter selection. Two mutations, the
T32A and N67A mutations, were incompatible with cell vi-
ability, as the corresponding strains did not grow on 5FOA
medium. All the other mutant cells were viable at 30◦C.
Quantification of the termination efficiency of yeast eRF1
mutants
Stop codon readthrough regulates gene expression in sev-
eral organisms (30–33). These recoding motifs divert the
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Figure 2. Impact of alanine mutations on readthrough efficiency. The fold-increase in readthrough induced by the alanine mutations with respect to the
wild-type protein is shown for each stop codon; the impact on readthrough is represented by a gradient from yellow to red. Lethal mutations are shown in
light blue.
ribosome to efficiently promote the incorporation of a
near-cognate tRNA (34). They are very useful to quantify
increase or decrease in translation termination efficiency
(whereas only decreases in termination efficiency can be
quantified using efficient stop codon contexts) (27).We used
these sequences to assess the impact of themutations on ter-
mination efficiency, by quantifying stop codon readthrough
in the strains bearingmutant eRF1 plasmids, using the pAC
dual reporter systemwithUAA,UAGorUGA (in theTMV
readthrough context) at the lacZ-luc junction (29). Weaker
termination efficiency corresponds to an increase in stop
codon readthrough efficiency. Readthrough was quantified
and compared with that obtained in the presence of the
wild-type plasmid. We assessed the effects of nine muta-
tions on translation termination efficiency at the three stop
codons (Supplementary Figure S1 and Figure 2). We clas-
sified the mutations into four groups, according to their ef-
fects on termination efficiency. The first category included
the R65A, K109A, L69A and V66A mutations, which in-
creased readthrough for all three stop codons. The L69A
mutant had a slightly stronger effect on UAG codons than
on the other stop codons (Figure 2 and Supplementary Fig-
ure S1B), suggesting that the leucine residue in this posi-
tion might be important for the recognition of the gua-
nine residue in the third position of the codon. The replace-
ment of the arginine and lysine residues in positions 65 and
109 with alanine residues resulted in the highest level of
readthrough, with the R65A mutation causing at least a
6-fold increase in readthrough at UAA and UAG codons
(Figure 2 and Supplementary Figure S1A and B), and the
K109A mutation increasing readthrough at UAG codons
by a factor of up to eight (Figure 2 and Supplementary
Figure S1B). The second category included the T99A and
E107A mutations, which decreased readthrough efficiency,
by a factor of two, at all three stop codons. The N30A mu-
tation, by contrast, had no significant impact on termina-
tion efficiency (Figure 2 and Supplementary Figure S1). The
most interesting category was probably that containing the
S33A and S70A mutations, which increased readthrough,
specifically at the UGA stop codon (Figure 2 and Supple-
mentary Figure S1C). Indeed, these two mutations resulted
in a readthrough efficiency eight times higher than that of
the wild-type protein at UGA stop codons, whereas termi-
nation at UAA and UAG codons was similar to that ob-
served for the wild-type strain. The distance between the
two serine residues is compatible with hydrogen bonding be-
tween them.A loss of interaction in the two alaninemutants
may therefore account for their similar effects on translation
termination (as both mutations would disrupt the same in-
tramolecular interaction).
The nucleotide context of the stop codon can greatly af-
fect termination efficiency. We therefore investigated the in-
fluence of the stop codon environment, using the alanine
mutant proteins with the strongest effects on stop codon
readthrough. We used the three stop codons in an effi-
cient termination environment, to quantify readthrough ef-
ficiency for these mutants. In this new nucleotide context,
we again observed an increase in readthrough efficiency for
the R65A and K109A mutant proteins, for all three stop
codons (Supplementary Figure S2), with readthrough lev-
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Figure 3. (A) Readthrough efficiency in the TMV context for alanine, threonine and cysteine mutants at positions 33 and 70, for the UGA stop codon. The
lines in the centres of the boxes indicate the median values; the box limits indicate the 25th and 75th percentiles calculated with R software; the whiskers
extend to the minimum and maximum values; data points are plotted as open circles. n ≥ 5 sample points. Wild-type values are indicated in white boxes;
mutant protein values are indicated in grey boxes. Readthrough efficiency is shown for the UGA stop codon. Wild-type, S33A and S70A values were
identical to those shown in Supplementary Figure S1. (B) Readthrough efficiency in the TMV context, for alanine mutants of the yeast and human eRF1
P1 pocket. The lines in the centres of the boxes indicate the median values; the box limits indicate the 25th and 75th percentiles calculated with R software;
the whiskers extend to the minimum and maximum values; data points are plotted as open circles. n ≥ 5 sample points. The values obtained with human
eRF1 are indicated in white boxes. The values obtained with the yeast eRF1 (Sup45p) are indicated in grey boxes.
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Figure 4. Impact of alanine mutations on the structural conformation of the eRF1 N domain. (A) NMR spectra of the N domains of heRF1 mutants.
Proteins are labelled with 15N. Proton chemical shifts are represented on the horizontal axis, with nitrogen on the vertical axis. Minimal map values were
calculated from peaks displaying a shift between the wild-type (in black) and mutant (in red) HSQC spectra. (B) Location of the observed chemical shifts
on the structure of the eRF1N domain. The most significant shifts are highlighted in red, and the least significant shifts are shown in yellow. The YxCxxxF
(black circle) and NIKS motifs are indicated.
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Figure 5. Interactions between the stop codon and the eRF1 N-terminal domain. (A) The first step in the recognition process, with the stop codon located
near the NIKS motif (K63 in red) and the P-site tRNA shown in orange on the left. (B) Second step in the recognition process, involving the interaction of
the stop codon with the P1 pocket. The P-site tRNA is shown in orange on the left. (C) The interaction between the stop codon and the P1 pocket requires
changes in the conformation of the N domain. eRF1 is shown in grey for the conformation adopted during the first step, as in panel (A), and in blue for
the conformation adopted during the second step. The P-site tRNA is not shown, for the sake of clarity. (D) As in panel (B), eRF1 is in the conformation
required for the second step of stop codon recognition, with K63 indicated in red.
Figure 6. Proposed model of translation termination by eRF1. The stop codon is recognized by eRF1 in complex with eRF3. Following GTP hydrolysis,
eRF3 is released and replaced by ABCE1, inducing changes in the conformation of the eRF1 N domain. These structural changes allow the stop codon
to interact with the P1 pocket and the GGQ motif to be in close proximity to the CCA end of the P-site tRNA for the induction of peptide release before
ribosome dissociation.
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els at least six times greater thanwild-type levels forR65Aat
UGA codons (Supplementary Figure S2C) and four times
wild-type levels for K109A at UAG codons (Supplemen-
tary Figure S2B). The S33A and S70A mutant proteins dis-
played high levels of readthrough, specifically at the UGA
codon (Supplementary Figure S2C). Thus, the nucleotide
context of the stop codon has no impact on the readthrough
phenotype of eRF1 mutants.
Genetic analysis of the contributions of the serine 33 and ser-
ine 70 residues to termination efficiency
The S33A and S70Amutants had identical termination effi-
ciency phenotypes. We analysed these mutations further, by
investigating the possibility that they might act in synergy.
We constructed the S33A-S70A double mutant and mea-
sured readthrough at the three leaky stop codons. The ter-
mination profile for the double mutant was similar to that
of the two single mutants, S33A and S70A (Figure 3A).
Indeed, the S33A-S70A mutant displayed an increase in
readthrough specifically with the UGA codon (34%), al-
though this increase was slightly smaller than that observed
for each single mutant, at only five times the wild-type
readthrough level (7%). As for the single mutants, termina-
tion efficiency at the UAA and UAG stop codons was not
affected by the presence of the double alanine mutation.
These phenotypes were compatible with the hypotheti-
cal presence of a hydrogen bond between the two serine
residues. We therefore replaced these residues with thre-
onine residues, which are chemically similar in that they
can form hydrogen bonds via their alcohol groups. We rea-
soned that if this potential interaction between the two
amino acids was involved in stop codon recognition, then
the replacement of serine residues with threonine residues
would have no effect on termination efficiency. We there-
fore constructed the S33T and S70T mutants and quanti-
fied readthrough efficiency at the three stop codons. Unex-
pectedly, we found that the twomutants behaved differently.
The S33T mutant yielded higher levels of readthrough than
the alanine mutant, with 72% at the UGA codon, whereas
the S70T mutation almost completely restored termination
efficiency to wild-type levels at the UGA stop codon (7%)
(Figure 3A). Thus, an ability to form a hydrogen bond is the
key determinant feature of the S70 residue. We decided to
investigate whether the chemical structure of these residues
was also important. We replaced the serine residues with
cysteine residues, which are structurally homologous, rea-
soning that if chemical structure was the key determinant,
then this change would have no impact on translation ter-
mination efficiency. The readthrough quantification results
revealed that the S33C and S70C mutants had phenotypes
similar to that of the alanine mutants with the UGA codon.
Readthrough levels of 45 and 65% were measured for the
S33C and S70Cmutants, respectively, corresponding to lev-
els 7 and 10 times those recorded for the wild-type protein
for the UGA codon (Figure 3A). Thus, at position 33, both
the structural and chemical properties of serine are impor-
tant for efficient terminationwhereas, at position 70, the key
feature seems to be an ability to hydrogen bond.
Conformational analysis of the S33A, S70A, R65A and
K109A mutant proteins by NMR on the N-terminal domain
of human eRF1
We investigated the effect of eRF1 mutations on termina-
tion efficiency in more detail, by performing NMR analy-
sis on some of the most interesting mutants. We analysed
the S33A and S70Amutants, which were considered partic-
ularly interesting because of their UGA specificity, and the
R65A andK109Amutants, which displayed very high levels
of readthrough for all three stop codons. These experiments
were performed with the human protein, so we first checked
that these mutations had similar impacts on termination ef-
ficiency for human eRF1 and yeast eRF1 (Figure 3B).
We produced and purified the 15N-labelled eRF1 N-
terminal domain of the wild-type protein and the four se-
lected mutant proteins, and performed 1H-15N HSQC ex-
periments with the purified proteins, to detect the chemical
shifts of each residue (Figure 4A and Supplementary Figure
S3). The chemical shifts of the backbone amides of the wild-
type and mutant N domains were compared by calculating
minimal map values on the basis of peaks displaying a shift
between wild-type and mutant 1H-15N HSQCs. The most
strongly affected residues are shown in red on the 3D struc-
ture of heRF1 (PDB 1DT9) for each mutant (Figure 4B).
NMR showed chemical shifts between the S70A mutant
and wild-type proteins to be minimal (Figure 4A and B),
indicating that the structural conformation of this mutant
differed little, if at all, from that of the wild-type protein. By
contrast, several significant shifts were common to the three
other mutants: S33A, R65A andK109A (Figure 4A and B).
The residues that are most strongly affected by the muta-
tions are well conserved between yeast and human. They
included, in particular, the universally conserved YxCxxxF
(125–131) motif, which is known to be involved in the de-
coding of the purines in the second and third positions of
the stop codon. The leucine 126 residue was found to have
shifted in the S33A, R65A and K109A mutants, and the
asparagine 129 and phenylalanine 131 residues displayed
shifts in the S33A and R65A mutants. The residues of the
conserved NIKS motif were affected in both the R65A and
K109A mutants (K63 and N61, respectively). In the S33A
and R65A mutants, we also detected a different conforma-
tion of the R28 andG29 residues, which are located close to
the GTS motif (31–33). The shifted amino acids detected in
both the R65A and K109A mutant proteins also included
S46, R68 and V110. With the exceptions of A8, V12 and
A138, all the shifted residues were located close to the mu-
tated positions, surrounding the P1 pocket. Thus, the im-
pact of the S33A, S70A, R65A and K109A mutations on
the conformation of the N domain appears to be local,
rather than remote.
DISCUSSION
Many studies involving mutagenesis or cross-linking
experiments have investigated the mechanism of stop
codon recognition by eukaryotic termination factor eRF1
(14,15,17). Some of these studies used in vitro reconstituted
translation systems to assay the activity of eRF1 mutants
and to identify the residues critical for stop codon recogni-
tion (22,26). Others used organisms with a variant genetic
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code to identify the amino acids of eRF1 responsible
for unipotency or bipotency (18,21–23). However, the
way in which eRF1 recognizes the stop codon remains
unclear. We used a combination of genetic approaches
and NMR to characterize a region of the eRF1 N domain
previously implicated in translation termination efficiency,
and potentially responsible for interactions with mRNA.
We performed alanine scanning mutagenesis over the P1
pocket region and measured the readthrough efficiency in
yeast for each resulting mutant. Two mutations, T32A and
N67A, were not compatible with viability. It is possible that
their location at the entrance of the pocket renders these two
residues critical for the correct conformation of this region
and that their replacement with alanine residues prevents
translation termination.We classified the alanine mutations
according to their impact on termination efficiency. L69A
was one of the mutations that increased readthrough levels
at all three stop codons. However, its slightly stronger effect
on UAG suggests that this residue may play an important
role in recognition of the guanine in the third position. The
S33A and S70A mutations constituted an interesting cate-
gory of mutations, with effects on readthrough specific to
the UGA stop codon. This phenotype has already been re-
ported for positions 33 and 70, but only in vitro (22,26). Our
findings provide the first demonstration of the importance
of these residues in vivo. There are two possible explanations
for the role of the serine 33 and 70 residues in UGA decod-
ing. First, both these residues may interact with the stop
codon, probably with the guanine residue in the second po-
sition. Second, theremay be a direct interaction between the
two serine residues which is critical for the recognition of the
guanine in the second position. The phenotype of the S33A-
S70A mutant, which was similar to that of the single mu-
tants, is more consistent with this second hypothesis (Fig-
ure 3A). Indeed, if both these residues interacted with the
stop codon, we would expect the double mutant to have a
stronger phenotype than the singlemutants.We investigated
the possible presence of a hydrogen bond between S33 and
S70, by replacing these residues individually with threonine
residues, a chemical homologue of serine. Quantification of
the level of readthrough induced by the S33T and S70Tmu-
tations revealed that the replacement of the serine residue
with a threonine residue at position 70 had almost no effect,
whereas a similar substitution at position 33 resulted in high
levels of readthrough at UGA codons (Figure 3A). Surpris-
ingly S30T has been previously reported to decrease UGA
recognition in vitro (26). This discrepancy probably reflects
either differences in termination stringency in vivo and in
vitro or differences in the termination process itself as the in
vitro data have been obtained with a stop codon very close
to the initiation codon (as a premature termination codon).
We believe that our results better represent the termination
process that occurs at the end of the coding sequences. Thus,
efficient UGA recognition requires the serine at position 70
to be able to form a hydrogen bond. However, this is clearly
not sufficient at position 33, as the S33T mutation does not
restore thewild-type phenotype.We then replaced the serine
residues with cysteine residues, which are similar in struc-
ture to serine residues but cannot form hydrogen bond. The
results obtained with these mutants confirmed our hypoth-
esis. The introduction of a cysteine residue to replace the
serine in position 70 did not restore wild-type termination,
highlighting the importance of hydrogen bond formation.
Similar results were obtained for position 33, demonstrating
the importance of the shape and chemical groups of serine
at this position.
We then carried out an NMR analysis on the S33A and
S70A mutant proteins, to add to the genetic data and build
amodel explaining the phenotypes observed. A comparison
of the spectra of the wild-type andmutant proteins revealed
that the S70Amutation had no significant impact on the lo-
cal conformation of the eRF1Ndomain (Figure 4A and B).
This is consistent with the observed levels of readthrough
and our hypothesis that the codon specificity of the S70A
mutant reflects the loss of a potential interaction, rather
than a change in local structure. By contrast, NMR for the
S33Amutant showed that the presence of an alanine residue
in this position led to local conformational changes in the
eRF1 N domain (Figure 4A and B). It also confirmed that
the shape of the serine residue at position 33 was important.
A comparison of the wild-type and S33A mutant proteins
spectra highlighted the shifts of theN129 and F131 residues
from the universally conserved YxCxxxF motif, which has
already been implicated in recognition of the second and
third bases (19,20). The serine 33 residue is part of the con-
served GTS loop, the conformation of which is modified by
mutations in the YxCxxxF motif or surrounding sequences
(25). Mutations affecting the GTS loop would thus be ex-
pected to induce changes in the conformation of the Yx-
CxxxF motif. The shifted residues in the S33A mutant also
included R28, G29, G31 and I35, which are located close to
S33 in the secondary sequence of the protein, but are prob-
ably too far away from this residue in the 3D structure to
interact directly with it. As for the YxCxxxFmotif residues,
the impact of mutations affecting these amino acids proba-
bly reflects local changes in conformation triggered by the
presence of the alanine residue. We suggest that a direct in-
teraction between S33 and S70 is required for the decoding
of the guanine residue in the second position. This inter-
action would imply a particular conformation of the GTS
loop, dependent on the YxCxxxF motif.
We characterized the P1 pocket in more detail, by study-
ing the R65A and K109A mutants by NMR. These mu-
tants displayed very high levels of readthrough at all three
stop codons (Figure 2 and Supplementary Figure S1). We
checked that this phenotype was not due to destabilization
of the mutant proteins, by western blotting to assess their
production and stability (Supplementary Figure S4). It is
possible that R65 and K109 are directly involved in the de-
coding of the uracil residue in first position and that the
mutation of these residues prevents stop codon recognition.
However, this hypothesis is not consistent with previous
findings of a direct interaction between this nucleotide and
the K63 residue of the NIKS motif (15). It appears more
plausible that R65 and K109 are important for the struc-
ture of the eRF1 N domain and, more specifically, for that
of the P1 pocket. As these two residues are located at the
edge of the cavity, we presume that they are critical for the
correct conformation of the pocket. NMR revealed shifts of
many residues with respect to the wild-type protein, in these
two mutant proteins. The K109A mutant displayed a less
marked change in conformation, but many of the chemical
Nucleic Acids Research, 2015, Vol. 43, No. 6 3307
shifts observed were similar to those for the R65A mutant.
The key observation accounting for the effect of these mu-
tations on termination efficiency at the three stop codons is
probably their impact on the residues of the NIKS motif in
both the R65A and K109A mutants. Lysine and arginine
are both positively charged amino acids. This suggests the
possibility that they interact with RNA through the phos-
phate groups, which are negatively charged. Such an inter-
action might involve rRNA, but the orientation of the lat-
eral chain of the arginine 65 and lysine 109 residues is more
consistent with contact with the sugar-phosphate backbone
of the mRNA. The role of these two residues may be to po-
sition the mRNA correctly in the pocket. As observed for
the S33A mutant, some residues of the YxCxxxF motif are
strongly affected by the R65A and K109A mutations. We
suggest that, as for the GTS loop, the conformation of the
YxCxxxF motif is probably closely related to that of the P1
pocket. Thus, a mutation affecting one of these regions is
likely to result in changes in the conformation of the other.
Our results demonstrate the crucial role of the P1 pocket
in stop codon recognition. By combining genetic and struc-
tural data, we developed a model in which the stop codon
initially interacts with eRF1 via the NIKS motif and then
with the P1 cavity (Figure 5A and B). We showed that some
of the residues of the P1 pocket, such asR65 andK109, were
essential for the correct conformation of the cavity. These
residues potentially act together with T32 and N67 ensur-
ing the correct positioning of the mRNA. Others, such as
L69, may recognize the stop codon through direct interac-
tion. A thorough analysis of the roles of the serine 33 and
serine 70 residues implicated both in the recognition of the
guanine residue in the second position, probably via inter-
actions between these two residues. Structural analyses of
the mutant proteins with alanine residues in these positions
suggested that the direct interaction of these residues was
governed by the conformation of theYxCxxxFmotif, which
seems to play a key role in determining the conformation of
the GTS loop and, more generally, of the whole cavity. The
role of the YxCxxxF motif in stop codon recognition may
therefore be indirect, mediated through its impact on the
P1 pocket. Our model is consistent with the recently deter-
mined cryo-EM structure of the pretermination complex in
the mammalian ribosome (13). Indeed, the interaction of
the stop codon with P1 would necessitate large conforma-
tional changes within N domain (Figure 5C), potentially
corresponding to those observed on cryo-EM. Our model
supports a two-step process of stop codon recognition, as
suggested by other groups (26,35). We suggest that the stop
codon is recognized through the NIKS motif when eRF1
enters the ribosome in association with eRF3. Following
the release of eRF3, the binding of ABCE1/Rli1 induces
changes in the conformation of the eRF1 N domain allow-
ing the stop codon to reach the P1 pocket, where the sec-
ond and third nucleotides are decoded (Figure 6). This new
model is entirely consistent with the latest cryo-EM data
and published genetic and biochemical findings. Given the
importance of P1 in stop codon recognition, it would be in-
teresting to search for drugs able to bind to this cavity and,
thus, to inhibit translation termination. This would induce a
strong suppressor phenotype that might help to restore the
expression of proteins inactivated by a premature termina-
tion codon in genetic diseases.
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